10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Short summary

At a median of 10 years, prostate cancer mortality was low and not significantly different across active monitoring, surgery, or radiotherapy groups (n=1643). However, surgery and radiotherapy led to significantly lower rates of disease progression and metastases compared to active monitoring.

AI-generated from the title and abstract; the full text is not read.